Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


Autoimmune Disease Therapeutics Market in Asia Pacific is expected to register a CAGR of 5.72% during the forecast period (2019-2025) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Autoimmune Disease Therapeutics Market, published by KBV research, the Asia Pacific Autoimmune Disease Therapeutics Market would witness market growth of 5.72% CAGR during the forecast period (2019-2025).

The China market dominated the Asia Pacific Anti-Hyperglycemics Market by Country in 2018, growing at a CAGR of 3.7 % during the forecast period. The Japan market is expected to witness a CAGR of 6.9% during (2019-2025). Additionally, The India market is expected to witness a CAGR of 7% during (2019-2025).

The Retail Pharmacies and Drug Stores market dominated the Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel in 2018growing at a CAGR of 5.6 % during the forecast period. The Online market is expected to witness a CAGR of 6% during (2019-2025).

The Rheumatic Disease market dominated the Malaysia Autoimmune Disease Therapeutics Market by Indication in 2018, thereby, achieving a market value of $716.1 million by 2025, growing at a CAGR of 7.4 % during the forecast period. The Multiple Sclerosis market is expected to witness a CAGR of 7.5% during (2019-2025).

Full Report: https://www.kbvresearch.com/asia-pacific-autoimmune-disease-therapeutics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Asia Pacific Autoimmune Disease Therapeutics Market Segmentation

By Indication

  • Rheumatic Disease
  • Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Other Indications

By Drug Class

  • Anti-Inflammatory
  • Anti-Hyperglycemics
  • NSAIDs
  • Interferons
  • Other Drugs

By Distribution Channel

  • Hospital Pharmacy
  • Online
  • Retail Pharmacies and Drug Stores

By Country

  • China Autoimmune Disease Therapeutics Market
  • Japan Autoimmune Disease Therapeutics Market
  • India Autoimmune Disease Therapeutics Market
  • South Korea Autoimmune Disease Therapeutics Market
  • Singapore Autoimmune Disease Therapeutics Market
  • Malaysia Autoimmune Disease Therapeutics Market
  • Rest of Asia Pacific Autoimmune Disease Therapeutics Market

Companies Profiled

  • ABBOTT Laboratories
  • Bio-Rad Laboratories, Inc.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck and Co., Inc.
  • Bayer AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Novartis AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Autoimmune Disease Therapeutics Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market



SUBSCRIPTION MODEL